The US Food and Drug Administration (FDA) has sent warning letters to five marketers of delta-8 THC products based on health claims the companies made.

The letters are the first sent by the FDA on delta-8 products. However, they largely mirror ones previously sent to companies that made health claims about CBD indeed several of the companies involved were also warned about CBD claims.

And although health claims appear to be what triggered the warnings, the FDA took a much larger swipe at delta-8 products generally.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us